These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 17548243)
1. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ; Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243 [TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Ashman TA; Cantor JB; Gordon WA; Spielman L; Flanagan S; Ginsberg A; Engmann C; Egan M; Ambrose F; Greenwald B Arch Phys Med Rehabil; 2009 May; 90(5):733-40. PubMed ID: 19406291 [TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB Breast J; 2006; 12(2):114-22. PubMed ID: 16509835 [TBL] [Abstract][Full Text] [Related]
4. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study. Lin CH; Lin SH; Jang FL J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699 [TBL] [Abstract][Full Text] [Related]
5. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline. Brady KT; Clary CM Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296 [TBL] [Abstract][Full Text] [Related]
6. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823 [TBL] [Abstract][Full Text] [Related]
7. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial. Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474 [TBL] [Abstract][Full Text] [Related]
8. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Banerjee S; Hellier J; Romeo R; Dewey M; Knapp M; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A Health Technol Assess; 2013 Feb; 17(7):1-166. PubMed ID: 23438937 [TBL] [Abstract][Full Text] [Related]
9. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125 [TBL] [Abstract][Full Text] [Related]
10. Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study. Amidfar M; Khiabany M; Kohi A; Salardini E; Arbabi M; Roohi Azizi M; Zarrindast MR; Mohammadinejad P; Zeinoddini A; Akhondzadeh S J Clin Pharm Ther; 2017 Feb; 42(1):44-50. PubMed ID: 27809351 [TBL] [Abstract][Full Text] [Related]
11. The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study. Bloch M; Meiboom H; Lorberblatt M; Bluvstein I; Aharonov I; Schreiber S J Clin Psychiatry; 2012 Feb; 73(2):235-41. PubMed ID: 22401479 [TBL] [Abstract][Full Text] [Related]
12. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT. Sarris J; Fava M; Schweitzer I; Mischoulon D Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504 [TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725 [TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788 [TBL] [Abstract][Full Text] [Related]
15. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115 [TBL] [Abstract][Full Text] [Related]
16. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial. Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738 [TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial. Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916 [TBL] [Abstract][Full Text] [Related]
18. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901 [TBL] [Abstract][Full Text] [Related]
19. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial. Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. Lydiard RB; Stahl SM; Hertzman M; Harrison WM J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]